# University of Texas MD Anderson Cancer Center – FDA Inspection, Oct 26, 2017

Source: https://www.keypedia.com/records/fda_inspections/university-of-texas-md-anderson-cancer-center/d787b14f-8a35-4532-833e-d9891b6fabcf
Source feed: FDA_Inspections

> FDA inspection 1030030 of University of Texas MD Anderson Cancer Center, October 26, 2017. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 606. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1030030
- Company Name: University of Texas MD Anderson Cancer Center
- Inspection Date: 2017-10-26
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1167810 - 2022-03-24

## Related Officers

- [Company Rep](https://www.keypedia.com/people/maira-p-brading/892072f4-e584-48d1-890c-e0a47dfbdffa)

Company: https://www.keypedia.com/companies/university-of-texas-md-anderson-cancer-center/3dbc2488-0079-4d5c-a6e5-0cc8ada2709c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d